: iStockAnalyst.com Symbols Feed

Which Healthcare Companies Could Benefit From Obama's Government Healthcare Plan?

Mon, 02 Mar 2009 17:52:52 GMT

As promised during his election campaign, President Obama seems to be swiftly acting on the US healthcare reform.[More...]

Earnings Review: February 19, 2009

Thu, 19 Feb 2009 23:39:03 GMT

Late on Thursday, AmSurg Corp. (NASDAQ: AMSG) announced that its fourth quarter fell to $11.71 million or 37 cents a share from $12.72 million or 40 cents a share in the year-ago quarter.[More...]

New Preventive Medicine Index

Sun, 25 Jan 2009 18:49:00 GMT

One of the major reasons behind Pfizer's (PFE) interest in acquiring Wyeth (WYE) is the latter's focus on products outside of traditional pharmaceuticals – with 60% of Wyeth's revenue from last year derived from biological therapeutics and vaccines. It remains to be seen what happens to Wyeth's proposed deal to acquire Dutch vaccine maker Crucell (CRXL); however since it is much smaller (around $1B) and focuses on the development of vaccines, Pfizer would likely be interested in both companies[More...]

Stocks Resume Selloff As Distribution Day Rattles Investors Who Bought Last Weeks LAME Rally

Tue, 02 Dec 2008 05:33:00 GMT

Do people not pay attention to volume at all? I am starting to begin they don’t after listening to all the typical talking loud-mouths this weekend. They all clamored and were happy the indexes were up 15% to 20% last week. Yet not a single person anywhere mentioned that volume was lower and lower each day as the rally went along. They also did not mention that we were right near/at the 50 day moving averages which are in a downtrend on all the indexes. Leaving these two key facts out made anything they said irrelevant. There was always a possibility of waking up and seeing a market running away today but the truth is this market is predictable yet insanely impossible to trade unless you are a daytrader. After my initial short positions before the selloff really started, things have been harder to manage as shorts are not going down in a smooth line like they should in a bear market. This is making for a very difficult trading environment and why unless[More...]

Stocks Continue The Selloff With Volume Finally Picking Up On The Selling

Fri, 21 Nov 2008 04:00:00 GMT

Today can be called nothing other than nasty as most of the indexes made round trips back to either six-year or eleven-year lows, following a nasty selloff that came on very heavy volume. Volume picked up on every exchange as finally some signs of panic selling hit the market. This selling took the markets off around 5% to 6% and a lot of stocks were just walloped. Now while I have continued to talk about the nasty downtrend this market is in and how well my shorts have been doing: top short holdings and total returns: IPHS 44% POT 65% GGB 72% SBAC 66% CYT 69% MOS 74% CETV 89% CPRT 28% AZO 24% RDK 17% AMX 49% PLCE 38% CAJ 34% SPG 52% CEO 51% AAPL 50% ENB 24% K 18% ARB 67% AMSG 20% SPW 77% RIMM 58% LLL 37% CEDC 65% APD 55% OKE 46% SDA 80% TITN 59% PAA 28%). I don’t believe I have seen the market in such a bleak condition in a long time and think I need to tell you about the lack of bullish items out there. To start it all off only 3% of[More...]

Analyst Comments: Amsurg, General Motors, Kookmin Bank, MIPS Technologies, POSCO

Mon, 21 Jul 2008 21:55:00 GMT

AmSurg Corporation (AMSG), which is expected to report 2Q08 financial results on July 22. Our current revenue and EPS estimates are $152 million and 39 cents, respectively, versus consensus estimates of $149 million and 39 cents.[More...]

AmSurg Corp. Announces That Steven I. Geringer Succeeds Thomas G. Cigarran as Chairman of the Board of Directors

Thu, 23 Jul 2009 20:13:00 GMT

AmSurg Corp. (Nasdaq: AMSG) today announced Steven I. Geringer, who has been an AmSurg director since 1997, has succeeded Thomas G. Cigarran as Chairman of the Board of Directors. Mr. Cigarran will continue to serve as an AmSurg director, having served as Chairman since 1992 when the Company was founded.[More...]

AmSurg Announces Second-Quarter Net Earnings from Continuing Operations of $0.45 Per Diluted Share

Thu, 23 Jul 2009 19:57:00 GMT

Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp. (NASDAQ: AMSG), today announced financial results for the second quarter ended June 30, 2009. Revenues increased 12% to $168,844,000 for the quarter from $150,722,000 for the second quarter of 2008. Net earnings from continuing operations attributable to AmSurg common shareholders increased 11% to $13,798,000 from $12,444,000. Net earnings from continuing operations per diluted share attributable to AmSurg common shareholders increased 15% to $0.45 for the second quarter of 2009 from $0.39 for the second quarter of 2008. As expected, the results for the second quarter of 2009 included an incremental negative impact of $0.02 per diluted share from the effect of the Medicare rule revising the payment system for ASCs, which was effective January 1, 2008. This negative impact was largely offset by the Company’s stock repurchases in the fourth quarter of 2008 and the first quarter of 2009.[More...]

AmSurg Corp. to Broadcast 2009 Second Quarter Conference Call Live on the Internet

Thu, 09 Jul 2009 19:33:00 GMT

AmSurg Corp. (Nasdaq: AMSG) today announced it will provide an on-line Web simulcast and rebroadcast of its 2009 second quarter earnings release conference call. The live broadcast of AmSurg Corp.’s quarterly conference call will be available on-line by going to http://www.amsurg.com and clicking on the link to Investor Relations, or at http://www.earnings.com. The call is scheduled to begin at 5:00 p.m. Eastern Time on Thursday, July 23, 2009. The on-line replay will follow shortly after the call and continue for 30 days.[More...]

AmSurg Corp. to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference

Wed, 06 May 2009 15:57:00 GMT

AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the Bank of America and Merrill Lynch 2009 Health Care Conference on Tuesday, May 12, 2009, in New York City. In connection with the conference, there will be an on-line simulcast and a replay of the Company’s presentation available at the Company’s web site starting at 2:00 p.m. Eastern Time. Christopher A. Holden, President and Chief Executive Officer, and Claire M. Gulmi, Executive Vice President, Chief Financial Officer and Secretary, will be speaking at the conference.[More...]

AmSurg Reports Net Earnings from Continuing Operations of $0.40 Per Diluted Share for the First Quarter of 2009

Thu, 23 Apr 2009 20:00:00 GMT

Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp. (NASDAQ: AMSG), today announced financial results for the first quarter ended March 31, 2009. Revenues increased 12% for the quarter to $163,533,000 from $145,729,000 for the first quarter of 2008. Net earnings from continuing operations attributable to AmSurg common shareholders increased 8% to $12,603,000, or $0.40 per diluted share, from $11,619,000, or $0.37 per diluted share, for the first quarter of 2008. As expected, the results for the first quarter of 2009 include an incremental negative impact of $0.02 per diluted share from the effect of the Medicare rule revising the payment system for ASCs, which was effective January 1, 2008.[More...]

AmSurg Corp. to Broadcast 2009 First Quarter Conference Call Live on the Internet

Fri, 03 Apr 2009 15:07:00 GMT

AmSurg Corp. (NASDAQ:AMSG) today announced it will provide an on-line Web simulcast and rebroadcast of its 2009 first quarter earnings release conference call. The live broadcast of AmSurg Corp.’s quarterly conference call will be available on-line by going to http://www.amsurg.com and clicking on the link to Investor Relations, or at http://www.earnings.com. The call is scheduled to begin at 5:00 p.m. Eastern Time on Thursday, April 23, 2009. The on-line replay will follow shortly after the call and continue for 30 days.[More...]

Zacks Bull & Bear of the Day Highlights: AmSurg Corporation, Zimmer Holdings, Gannett, New York Times and PMI Group

Tue, 17 Mar 2009 11:10:00 GMT

Zacks Equity Research picks AmSurg Corporation (Nasdaq: AMSG) as Bull of the Day and Zimmer Holdings, Inc. (NYSE: ZMH) as Bear of the Day.
In addition, the analysts at Zacks Equity Research discuss the latest on Gannett (NYSE: GCI), The New York Times (NYSE: NYT) and PMI Group, Inc. (NYSE: PMI).
Full analysis of all these stocks is available at: http://at.zacks.com/?id=2678

[More...]

Zacks Analyst Blog Highlights: Hanesbrands Inc, Sara Lee Corp, Allied Irish Banks Plc, Cumulus Media and AmSurg Corp.

Tue, 17 Mar 2009 11:10:00 GMT

Zacks.com announces the list of stocks featured in the Analyst Blog.
Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
Stocks recently featured in the blog include: Hanesbrands Inc (NYSE: HBI), Sara Lee Corp (NYSE: SLE), Allied Irish Banks Plc (NYSE: AIB), Cumulus Media (NASDAQ: CMLS) and AmSurg Corp (NASDAQ: AMSG).

[More...]

AmSurg Corp. to Present at the Raymond James 30th Annual Institutional Investors Conference

Tue, 03 Mar 2009 15:45:00 GMT

AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the Raymond James 30th Annual Institutional Investors Conference on Tuesday, March 10, 2009, in Orlando, Florida. In connection with the conference, there will be an on-line simulcast and a replay of the Company’s presentation available at the Company’s web site starting at 2:50 p.m. Eastern Time. Christopher A. Holden, President and Chief Executive Officer, and Claire M. Gulmi, Executive Vice President, Chief Financial Officer and Secretary, will be speaking at the conference.[More...]

AmSurg Fourth-Quarter Net Earnings from Continuing Operations Increase 11% to $0.40 Per Diluted Share

Thu, 19 Feb 2009 20:02:00 GMT

Christopher A. Holden, President and Chief Executive Officer of AmSurg Corp. (NASDAQ: AMSG), today announced record financial results for the fourth quarter and 12 months ended December 31, 2008. Revenues for the quarter were $153,146,000, an increase of 8% from $141,482,000 for the fourth quarter of 2007. Net earnings from continuing operations rose 13% to $12,862,000 from $11,367,000. Net earnings from continuing operations per diluted share increased 11% to $0.40 for the fourth quarter of 2008 from $0.36 for the same quarter in 2007. As expected, net earnings from continuing operations for the fourth quarter of 2008 included a negative impact of $0.01 per diluted share from the effect of the Medicare rule revising the payment system for ASCs, which was effective January 1, 2008.[More...]